Metastatic BRAF K601E-mutated melanoma reaches complete...

Experimental Hematology and Oncology 2017 / 12 Vol. 6; Iss. 1

Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months

Marconcini, Riccardo, Galli, Luca, Antonuzzo, Andrea, Bursi, Simona, Roncella, Claudia, Fontanini, Gabriella, Sensi, Elisa, Falcone, Alfredo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Journal:
Experimental Hematology & Oncology
DOI:
10.1186/s40164-017-0067-4
Date:
December, 2017
File:
PDF, 1.80 MB
english, 2017
Conversion to is in progress
Conversion to is failed